 CHESTER, N.Y.--BUSINESS WIRE--Repro Med Systems, Inc. dba KORU Medical Systems NASDAQ: KRMD KORU Medical or the Company, a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2020 financial results on March 23, 2021. KORU Medicals management will host a conference 